Venetoclax Plus BTK Inhibitor–Based Combinations Represent Promising Avenue in CLL/SLL
Supriya Gupta, MD, details pros/cons with different BTK inhibitors and promising combination therapies in CLL, as well as how liso-cel is affecting care.
Related Articles
CheckMate 9DW Expanded Analyses: Ipi/Nivo Versus Len/Sor | Docwire News
Additional analyses from the CheckMate 9DW study shed further light on the clinical efficacy and safety of ipi/nivo for uHCC.
Smartwatch technology may help detect lymphedema earlier
Enrollment is underway for a clinical trial that will evaluate whether smartwatch technology can allow for earlier detection of lymphedema.Lymphedema — a common complication that…
Gastrointestinal Cancers Symposium (ASCO GI)
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen
Drug is approved in combination with fludarabine
Conquering Overtreatment of DCIS: Lessons from PRECISION
Summary:. As we cannot reliably distinguish indolent, low-risk ductal carcinoma in situ (DCIS) from potentially progressive, high-risk DCIS, all women with DCIS diagnosis undergo intensive…
Custom smartwatch could detect early signs of painful condition that impacts 90 million cancer survivors
Smartwatches have transformed the way many people communicate and track their health habits. Now researchers at OSUCCC – James are testing whether these
CRU Eye Symposium Wine Personality Quiz
Calling all eye care professionals looking to attend the CRU Eye Symposium this year! Are you curious about which wine matches your personality? Find out…
Nominations
NOMINATE The Giants of Cancer Care ® program, presented by OncLive ®, recognizes and celebrates the individuals who have achieved landmark successes within the global…
Neoadjuvant Sintilimab Plus Chemoradiotherapy Improves pCR Rate in Resectable, Locally Advanced ESCC
Neoadjuvant sintilimab plus chemoradiotherapy improved pCR rates in resectable, locally advanced esophageal squamous cell carcinoma.
PFOA, PFOS, and Related PFAS Chemicals
Learn about PFOA (and similar PFAS chemicals such as PFOS) and their possible effects on cancer risk here.